Does RUXOLITINIB Cause Pallor? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Pallor have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
138
Reports of Pallor with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
38
Deaths
78
Hospitalizations
How Dangerous Is Pallor From RUXOLITINIB?
Of the 138 reports, 38 (27.5%) resulted in death, 78 (56.5%) required hospitalization, and 15 (10.9%) were considered life-threatening.
Is Pallor Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Pallor?
SODIUM (2,745)
ASPIRIN (541)
INFLIXIMAB (456)
ADALIMUMAB (387)
CLOPIDOGREL BISULFATE (367)
INFLIXIMAB-DYYB (258)
HUMAN IMMUNOGLOBULIN G (254)
METHOTREXATE (250)
RITUXIMAB (243)
APIXABAN (238)
Which RUXOLITINIB Alternatives Have Lower Pallor Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE